{"id":"https://openalex.org/W5766544","doi":null,"title":"Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction.","display_name":"Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction.","alternate_titles":[],"publication_year":2002,"publication_date":"2002-09-01","ids":{"openalex":"https://openalex.org/W5766544","mag":"5766544","pmid":"https://pubmed.ncbi.nlm.nih.gov/12683423"},"language":"en","primary_location":{"id":"pmid:12683423","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12683423","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hypertension. Supplement : official journal of the International Society of Hypertension","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W5766544"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035092157","display_name":"Murray Epstein","orcid":"https://orcid.org/0000-0002-7897-4812","observed_orcids":["https://orcid.org/0000-0002-7897-4812"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Murray Epstein","raw_affiliation_strings":["Department of Medicine, University of Miami School of Medicine, Miami, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Miami School of Medicine, Miami, Florida, USA","institution_ids":["https://openalex.org/I145608581"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5035092157"],"corresponding_institution_ids":["https://openalex.org/I145608581"],"apc_list":null,"apc_paid":null,"fwci":1.7542,"has_fulltext":false,"cited_by_count":59,"citation_normalized_percentile":{"value":0.83274899,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"20","issue":"6","first_page":"S17","last_page":"S23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9589999914169312,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9589999914169312,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.011699999682605267,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9900000095367432},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.847000002861023},{"id":"https://openalex.org/keywords/cyclooxygenase-inhibition","display_name":"cyclooxygenase inhibition","score":0.9670000076293945},{"id":"https://openalex.org/keywords/prostaglandins","display_name":"prostaglandins","score":0.9800000190734863},{"id":"https://openalex.org/keywords/sodium-retention","display_name":"sodium retention","score":0.7490000128746033},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.8220000267028809},{"id":"https://openalex.org/keywords/renal-vasoconstriction","display_name":"renal vasoconstriction","score":0.9599999785423279},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.8190000057220459},{"id":"https://openalex.org/keywords/renal-hemodynamics","display_name":"renal hemodynamics","score":0.7089999914169312},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9311145544052124},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.6484100222587585},{"id":"https://openalex.org/C2781128415","wikidata":"https://www.wikidata.org/wiki/Q412050","display_name":"Prostacyclin","level":2,"score":0.6055063605308533},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.5508373975753784},{"id":"https://openalex.org/C2779961880","wikidata":"https://www.wikidata.org/wiki/Q1067506","display_name":"Vasoconstriction","level":2,"score":0.5041149854660034},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.49179843068122864},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4859112799167633},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.47840699553489685},{"id":"https://openalex.org/C120770815","wikidata":"https://www.wikidata.org/wiki/Q14859627","display_name":"Vasodilation","level":2,"score":0.471469908952713},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.4650743007659912},{"id":"https://openalex.org/C2781073237","wikidata":"https://www.wikidata.org/wiki/Q2894103","display_name":"Renal circulation","level":4,"score":0.46280190348625183},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44777625799179077},{"id":"https://openalex.org/C142225936","wikidata":"https://www.wikidata.org/wiki/Q1129139","display_name":"Renal blood flow","level":3,"score":0.4465031921863556},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.4410788118839264},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4156808853149414},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.41518017649650574},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1263471245765686},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D012079","descriptor_name":"Renal Circulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012964","descriptor_name":"Sodium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014867","descriptor_name":"Water","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058186","descriptor_name":"Acute Kidney Injury","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12683423","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12683423","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hypertension. Supplement : official journal of the International Society of Hypertension","raw_type":"Journal Article"},{"id":"mag:5766544","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12683423","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W114279531","https://openalex.org/W2154071008","https://openalex.org/W2023243818","https://openalex.org/W2398927124","https://openalex.org/W2099995466","https://openalex.org/W2096814043","https://openalex.org/W2005424427","https://openalex.org/W2098504866","https://openalex.org/W2358770515","https://openalex.org/W2070459919"],"abstract_inverted_index":{"Non-steroidal":[0],"anti-inflammatory":[1],"drugs":[2,151],"(NSAIDs)":[3],"are":[4,44,146,158],"used":[5],"to":[6,15,119,126,172,177],"treat":[7],"diverse":[8],"inflammatory":[9],"diseases":[10],"because":[11],"of":[12,28,79,82,93,100,103,124,131,179],"their":[13],"ability":[14,123],"inhibit":[16],"cyclooxygenase":[17],"(COX),":[18],"which":[19],"constitutes":[20],"the":[21,25,80,101,120,128,154],"rate-limiting":[22],"enzyme":[23,138],"in":[24,39,46],"biosynthetic":[26],"cascade":[27],"prostaglandin":[29],"(PG).":[30],"However,":[31],"NSAID":[32,104,107],"therapy":[33,108],"is":[34,117,170],"associated":[35],"with":[36,148,182],"adverse":[37],"changes":[38,45],"renal":[40,51,63,67,70,88,166,174],"function.":[41,72,89],"Most":[42],"prominent":[43],"electrolyte":[47],"homeostasis":[48],"and":[49,58,69,136,152,190],"impaired":[50],"perfusion.":[52],"PGs":[53,84,181],"such":[54,83],"as":[55],"PGE2,":[56],"PGF2a,":[57],"PGI2":[59],"(prostacyclin)":[60],"modulate":[61],"many":[62],"physiologic":[64],"effects,":[65],"including":[66,134,186],"haemodynamics":[68],"tubular":[71],"Consequently,":[73],"one":[74,91],"would":[75,85],"anticipate":[76],"that":[77],"impairment":[78],"synthesis":[81],"adversely":[86],"affect":[87],"About":[90],"fourth":[92],"NSAID-treated":[94],"patients":[95],"have":[96],"sodium":[97],"retention,":[98],"regardless":[99],"type":[102],"being":[105],"used.":[106],"may":[109,162],"also":[110],"cause":[111],"blood":[112],"pressure":[113],"destabilization.":[114],"This":[115],"destabilization":[116],"attributable":[118],"well":[121],"defined":[122],"NSAIDs":[125,161],"attenuate":[127],"antihypertensive":[129],"effects":[130],"several":[132],"agents":[133],"diuretics":[135],"angiotensin-converting":[137],"inhibitors.":[139],"Because":[140],"an":[141],"estimated":[142],"14":[143],"million":[144],"Americans":[145],"treated":[147],"both":[149],"anti-hypertensive":[150],"NSAIDs,":[153],"public":[155],"health":[156],"implications":[157],"clear.":[159],"Finally,":[160],"occasionally":[163],"produce":[164],"acute":[165],"failure.":[167],"The":[168],"pathogenesis":[169],"believed":[171],"be":[173],"vasoconstriction":[175],"secondary":[176],"inhibition":[178],"vasodilatory":[180],"unopposed":[183],"vasoconstrictor":[184],"forces":[185],"angiotensin":[187],"II,":[188],"catecholamines":[189],"enhanced":[191],"sympathetic":[192],"activity.":[193]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W5766544","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
